Show simple item record

dc.contributor.authorCokugras, Haluk
dc.contributor.authorCamcioglu, Yildiz
dc.contributor.authorOzsoy, Sevil
dc.contributor.authorKuijpers, Taco
dc.contributor.authorRoos, Dirk
dc.contributor.authorAygun, Deniz
dc.contributor.authorKÖKER, MUSTAFA YAVUZ
dc.contributor.authorNepesov, Serdar
dc.contributor.authorKÖKER, MUSTAFA YAVUZ
dc.contributor.authorvan Leeuwen, Karin
dc.contributor.authorde Boer, Martin
dc.contributor.authorKIYKIM, Ayça
dc.date.accessioned2021-03-02T18:20:23Z
dc.date.available2021-03-02T18:20:23Z
dc.date.issued2020
dc.identifier.citationAygun D., KÖKER M. Y. , Nepesov S., KÖKER M. Y. , van Leeuwen K., de Boer M., KIYKIM A., Ozsoy S., Cokugras H., Kuijpers T., et al., "Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease", INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, cilt.181, ss.540-550, 2020
dc.identifier.issn1018-2438
dc.identifier.othervv_1032021
dc.identifier.otherav_f2f34854-7640-4888-8545-a2932647e2a6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/4890
dc.identifier.urihttps://doi.org/10.1159/000507366
dc.description.abstractBackground:Chronic granulomatous disease (CGD) is a rare genetic disorder characterized by failure of phagocytic leukocytes to destroy certain microbes. We present a study on CGD patients enrolled at a single medical center concerning the infectious and noninfectious complications and genetic properties of the disease.Methods:Icotinamide adenine dinucleotide phosphate oxidase activity and the expression of flavocytochromeb(558) were measured by flow cytometry, and clinical outcomes of the patients were listed in relation to the genetic results.Results:The clinical and genetic findings of 32 pediatric cases with CGD from 23 families were enrolled. Pneumonia and anemia were the most common infectious and noninfectious symptoms. Genetic analysis showed that 10 families (43.5%) carriedCYBBvariants and 13 families (56.5%) have autosomal recessive (AR) CGD, in which 6 families (26%) carriedNCF1variants, 4 (17.4%) carriedCYBAvariants, and 3 (13%) carriedNCF2variants. The median age of clinical onset was 3.3 and 48 months for patients with X-linked CGD (X-CGD) and AR-CGD, respectively. The onset of symptoms before age 1 year was 94% in X-CGD, 28.5% in AR-CGD, and 12.5% in patients with oxidase residual activity. Moreover, a de novo germline mutation at c.1415delG inCYBB(OMIM#300481) and a novel c.251_263del13bp inCYBA(OMIM#608508) were also investigated.Conclusions:Ihydrorhodamine-1,2,3 assay could not detect carrier mother in de novo case withCYBBvariant. Most X-CGD patients have the onset of symptoms before age 1 year. Additionally, residual oxidase activity in AR-CGD causes a delay in onset, diagnosis, and prophylaxis. The protective role of residual activity is limited while the infection is ongoing and becoming serious.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectİmmünoloji
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectALERJİ
dc.subjectYaşam Bilimleri
dc.titleGenetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease
dc.typeMakale
dc.relation.journalINTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , ,
dc.identifier.volume181
dc.identifier.issue7
dc.identifier.startpage540
dc.identifier.endpage550
dc.contributor.firstauthorID2282257


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record